You are here

Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Pushing for top spot in Big Pharma, AbbVie lands a key approval for its blockbuster Skyrizi

Endpoints

Mon, 06/20/22 - 10:29 am

Tags:

AbbVie, Skyrizi, FDA, Crohn’s disease

AbbVie & Genmab EHA Data Indicate LBCL Drug Could Fill Unmet Need

BioSpace

Mon, 06/13/22 - 09:51 pm

Tags:

AbbVie, Genmab, clinical trials, LBCL, epcoritamab

AbbVie Inks Licensing Agreement To Use Sirona Biochem's New Skincare Technology

CP WIre

Mon, 06/13/22 - 12:54 pm

Tags:

Sirona Biochem, AbbVie, Allergan, aesthetics, TFC-1067

Mon, 06/13/22 - 12:39 pm

Tags:

Sirona Biochem, AbbVie, Allergan, aesthetics, TFC-1067

ASCO 2022 – the spirit of Rova-T struggles to live on

EP Vantage

Tue, 06/7/22 - 10:19 am

Tags:

ASCO 2022, Rova-T, AbbVie, Harpoon Therapeutics, Amgen, Boehringer Ingelheim

ASCO: J&J, AbbVie go back to Imbruvica's roots in lymphoma. Will lack of survival win matter?

Fierce Pharma

Fri, 06/3/22 - 10:27 am

Tags:

AbbVie, JNJ, ASCO 2022, FDA, Imbruvica, MCL

Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analysts

Fierce Pharma

Wed, 06/1/22 - 10:15 am

Tags:

AbbVie, Roche, Pfizer, Humira

Abbvie to become the biggest of pharmas in 2028

EP Vantage

Mon, 05/30/22 - 10:13 am

Tags:

AbbVie, Humira, Pfizer, Novartis, Bristol Myers Squibb, Roche

Teva, AbbVie's Allergan hand over $161M to settle opioid lawsuit in West Virginia

Fierce Pharma

Wed, 05/25/22 - 11:36 pm

Tags:

AbbVie, Allergan, Teva Pharmaceutical, legal, opioids, opioid crisis

The patent winter is coming

EP Vantage

Wed, 05/25/22 - 10:41 am

Tags:

patents, biosimilars, patent cliff, Keytruda, Opdivo, Eliquis, Darzalex, Revlimid, Humira, Stelara, AbbVie, Merck, Bristol Myers Squibb, JNJ

AbbVie adds to Vraylar data as FDA considers depression use

Pharmaforum

Tue, 05/24/22 - 10:43 am

Tags:

AbbVie, Vraylar, FDA, clinical trials, treatment-resistant depression

AbbVie faces yet another 'white-coat' lawsuit claiming it used kickbacks to help promote Humira

Fierce Pharma

Sun, 05/22/22 - 09:10 pm

Tags:

AbbVie, legal, kickbacks, fraud, Delaware, Humira

AbbVie asks FDA to approve Parkinson’s treatment

BioPharma Dive

Sun, 05/22/22 - 09:04 pm

Tags:

AbbVie, FDA, Parkinson's Disease, carbidopa/levodopa

Janssen Presents New Data that could Set Anti-Inflammatory Drug Apart

BioSpace

Thu, 05/19/22 - 09:00 pm

Tags:

JNJ, Janssen, Tremfya, Skyrizi, AbbVie, anti-inflammatories

Berkshire Hathaway pulls out of AbbVie, Bristol Myers Squibb investments

Endpoints

Wed, 05/18/22 - 10:19 am

Tags:

Berkshire Hathaway, Warren Buffet, AbbVie, Bristol Myers Squibb

Big pharma’s biggest spenders revealed

EP Vantage

Tue, 05/17/22 - 10:29 am

Tags:

R&D, licensing, M&A, COVID-19, Big Pharma, Bristol Myers Squibb, JNJ, AbbVie, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Roche, GSK, Eli Lilly

AbbVie and Cugene Announce Collaboration in Autoimmune Diseases

BioSpace

Mon, 05/16/22 - 10:28 am

Tags:

AbbVie, Cugene, CUG252, Treg cell therapy, autoimmune disease

Opportunities arise for once-spurned partners

EP Vantage

Fri, 05/13/22 - 10:34 am

Third positive trial sets up filings for AbbVie’s Rinvoq in Crohn’s

Pharmaforum

Thu, 05/12/22 - 10:46 am

Tags:

AbbVie, Rinvoq, clinical trials, Crohn’s disease

AbbVie, Teva looking to settle nationwide opioid litigation for $5B+: Bloomberg

Fierce Pharma

Wed, 05/11/22 - 11:05 pm

Tags:

AbbVie, Allergan, Teva Pharmaceutical, opioids, opioid crisis, legal

Pages

last 30 twitter posts